| Vorinostat | IC50 | 10000.0 [1] |
| Vorinostat | Ki | 129.0 [1] |
| Trichostatin A | IC50 | 139.0 [1] |
| Trichostatin A | Ki | 195.0 [1], 300.0 [2] |
| Panobinostat | IC50 | 2830.0 [1], 4354.0 [2] |
| Panobinostat | Ki | 2.3 [1], 630.0 [2], 4550.0 [3] |
| Tubastatin A | IC50 | 30000.0 [1] |
| Tubacin | IC50 | 9700.0 [1], 30000.0 [2] |
| Tubacin | Ki | 5426.9 [1], 8500.0 [2] |
| Entinostat | IC50 | 10000.0 [1], 50000.0 [2], 100000.0 [3] |
| Romidepsin | IC50 | 10000.0 [1], 50000.0 [2] |
| Romidepsin | Ki | 1250.0 [1] |
| Dacinostat | IC50 | 6.11 [1], 2240.0 [2] |
| Dacinostat | Ki | 9500.0 [1] |
| CID 53344908 | IC50 | 40.0 [1], 40.85 [2], 112.0 [3] |
| CID 53344908 | Ki | 46.3 [1] |
| Belinostat | Ki | 51.0 [1], 75.0 [2] |
| Mocetinostat | IC50 | 10000.0 [1] |
| Ricolinostat | IC50 | 1400.0 [1], 10000.0 [2] |
| Scriptaid | IC50 | 2100.0 [1] |
| Scriptaid | Ki | 2250.0 [1] |
| Quisinostat | Ki | 1.7 [1], 66.6 [2] |
| Givinostat | Ki | 240.0 [1] |
| 4-Acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | IC50 | 10000.0 [1], 20000.0 [2] |
| N-Hydroxy-2,2-diphenylacetamide | IC50 | 390.0 [1], 650.0 [2] |
| CID 24853793 | IC50 | 1.0 [1], 10000.0 [2] |
| N-(4-Hydroxybiphenyl-3-yl)benzamide | IC50 | 50000.0 [1] |
| N-Hydroxy-2-(1-methylpyrrole-2-carbonyl)-3,4-dihydro-1H-isoquinoline-6-carboxamide | IC50 | 50000.0 [1] |
| (1r,2r,3r)-2-[4-(5-Fluoranylpyrimidin-2-Yl)phenyl]-N-Oxidanyl-3-Phenyl-Cyclopropane-1-Carboxamide | IC50 | 110.0 [1], 120.0 [2] |
| N-[[4-(Hydroxycarbamoyl)phenyl]methyl]-1-methylpyrrole-2-carboxamide | IC50 | 4600.0 [1] |
| Valproic acid | IC50 | 2000000.0 [1] |
| Butyric acid | IC50 | 2000000.0 [1] |
| 4-Phenylbutyric acid | IC50 | 2000000.0 [1] |
| N-Hydroxybenzamide | IC50 | 15600.0 [1] |
| Largazole | IC50 | 10000.0 [1] |
| Pracinostat | Ki | 107.0 [1] |
| N-Hydroxy-1-(4-methoxybenzyl)-1H-indole-6-carboxamide | IC50 | 10.0 [1] |
| Cudc-101 | IC50 | 373.0 [1] |
| Fimepinostat | IC50 | 426.0 [1] |
| N-(2-Aminophenyl)benzamide | IC50 | 50000.0 [1] |
| 1-(3,4-Dihydroxyphenyl)-2-[(4-hydroxy-6-methylpyrimidin-2-YL)thio]ethanone | IC50 | 100000.0 [1] |
| Thailandepsin A | IC50 | 50000.0 [1] |
| Nexturastat A | IC50 | 4460.0 [1] |
| (E)-5-[4-(Benzenesulfonamido)phenyl]-N-hydroxypent-2-en-4-ynamide | Ki | 324.7 [1] |
| N-Hydroxy-4-[(14-methyl-13,15-dioxo-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraen-9-yl)methyl]benzamide | Ki | 442.0 [1] |
| Azumamide E | IC50 | 9700.0 [1] |
| N-Hydroxy-4-phenylbutanamide | IC50 | 150000.0 [1] |
| N-(6-(2-Aminophenylamino)-6-oxohexyl)-4-methylbenzamide | IC50 | 180000.0 [1] |
| 9,9,9-Trifluoro-8-Oxo-N-Phenylnonanamide | Ki | 4.7 [1] |
| 2-[(4-Methyl-6-oxo-1,6-dihydropyrimidin-2-yl)sulfanyl]-N-(2-phenylethyl)acetamide | IC50 | 100000.0 [1] |
| 2-[(4-Hydroxy-6-methylpyrimidin-2-yl)sulfanyl]-1-(4-methoxyphenyl)ethanone | IC50 | 100000.0 [1] |
| N-(Quinolin-8-YL)-6-(2-sulfanylacetamido)hexanamide | IC50 | 2780.0 [1] |
| N-(4-Aminobiphenyl-3-yl)benzamide | IC50 | 50000.0 [1] |
| 4-[2-[2-Hydroxyethyl(Phenyl)amino]-2-Oxidanylidene-Ethyl]-~{n}-Oxidanyl-Benzamide | IC50 | 10000.0 [1] |
| N-(2-Aminophenyl)-N'-phenylheptanediamide | IC50 | 180000.0 [1] |
| N-Hydroxy-2-(4-(naphthalen-2-ylsulfonyl)piperazin-1-yl)pyrimidine-5-carboxamide | IC50 | 46.0 [1] |
| HDAC inhibitor | IC50 | 1293.0 [1] |
| N-(4-{[(4-Hydroxy-6-methylpyrimidin-2-yl)sulfanyl]acetyl}phenyl)acetamide | IC50 | 24400.0 [1] |
| (S)-Benzyl (6-acetamido-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate | IC50 | 785.9 [1] |
| N-(2-Amino-phenyl)-nicotinamide | IC50 | 50000.0 [1] |
| 6-Methyl-2-{[2-oxo-2-(thiophen-2-yl)ethyl]sulfanyl}-3,4-dihydropyrimidin-4-one | IC50 | 100000.0 [1] |
| N-Hydroxy-5-[[6-oxo-4-(4-phenylphenyl)-1H-pyrimidin-2-yl]sulfanyl]pentanamide | IC50 | 50000.0 [1] |
| (E)-N-Hydroxy-3-[4-(4-methoxyphenyl)phenyl]prop-2-enamide | IC50 | 213000.0 [1] |
| 1-Methyl-N-[(1S)-1-(5-naphthalen-2-yl-1H-imidazol-2-yl)-7-oxooctyl]piperidine-4-carboxamide | IC50 | 1.0 [1] |
| Pimelic Diphenylamide 106 | IC50 | 100000.0 [1] |
| 6-(1-Adamantylcarbamoylamino)-N-hydroxyhexanamide | IC50 | 1290.0 [1] |
| N-Hydroxybutanamide | IC50 | 1000000.0 [1] |
| N-Hydroxy-5-(4-phenyltriazol-1-yl)pentanamide | IC50 | 18700.0 [1] |
| N-Hydroxy-9H-xanthene-9-carboxamide | IC50 | 50.0 [1] |
| N-[1-[[3-Azido-5-(azidomethyl)phenyl]methyl]pyrazol-4-yl]-N'-hydroxyoctanediamide | IC50 | 4510.0 [1] |
| Thailandepsin B | IC50 | 27000.0 [1] |
| 3-N-Hydroxy-1-N-(2-phenylethyl)benzene-1,3-dicarboxamide | IC50 | 13000.0 [1] |
| N-Hydroxy-2-propylpentanamide | IC50 | 99000.0 [1] |
| N-[(1S)-1-[5-(2-Methoxyquinolin-3-yl)-1H-imidazol-2-yl]-7-oxononyl]-1-methylazetidine-3-carboxamide | IC50 | 10000.0 [1] |
| N-Hydroxy-4-[(quinolin-8-ylamino)methyl]benzamide | IC50 | 709.0 [1] |
| 6-Methyl-2-phenacylsulfanyl-1H-pyrimidin-4-one | IC50 | 100000.0 [1] |
| 2-(4-Chlorophenacylthio)-4-hydroxy-6-methylpyrimidine | IC50 | 100000.0 [1] |
| Pandacostat | Ki | 1100.0 [1] |
| (E)-N-Hydroxy-3-[4-(4-hydroxyphenyl)phenyl]prop-2-enamide | IC50 | 15600.0 [1] |
| 2-(4-Methoxybenzyloxy)-N8-hydroxy-N1-phenyloctanediamide | IC50 | 432.0 [1] |
| (2E,4E)-N-[6-(Hydroxyamino)-6-oxohexyl]-3-methyl-5-phenyl-2,4-pentadienamide | IC50 | 4.4 [1] |
| (2E,4E)-N-Hydroxy-5-[4-(4-methoxyphenyl)phenyl]penta-2,4-dienamide | IC50 | 100000.0 [1] |
| N-(2-Amino-5-thiophen-2-ylphenyl)benzamide | IC50 | 50000.0 [1] |
| N-(4-Aminobiphenyl-3-yl)nicotinamide | IC50 | 50000.0 [1] |
| N-(2-Amino-5-(thiophen-2-yl)phenyl)nicotinamide | IC50 | 50000.0 [1] |
| 3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamide | Ki | 7000.0 [1] |
| 1-[5-[3-[4-(1,3,4-Oxadiazole-2-yl)phenoxymethyl]-1,2,4-oxadiazole-5-yl]-2-thienyl]trifluoroethanone | IC50 | 70.0 [1] |
| (3S,6S,9S,13S)-9-Methyl-13-(2-methylpropyl)-3-(naphthalen-1-ylmethyl)-6-(6-oxooctyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | IC50 | 10000.0 [1] |
| 5-[4-[[3-Azido-5-(azidomethyl)benzoyl]amino]phenyl]-N-[7-(hydroxyamino)-7-oxoheptyl]-1,2-oxazole-3-carboxamide | IC50 | 2230.0 [1] |
| (E)-N-Hydroxy-3-[4-(trifluoromethyl)phenyl]prop-2-enamide | IC50 | 100000.0 [1] |
| 2-((3-Phenethoxyphenyl)Amino)Benzamide | IC50 | 30000.0 [1] |
| N-(3,4-Dimethylphenyl)-2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoro-N'-hydroxyoctanediamide | Ki | 2500.0 [1] |
| (1r,2r,3r)-2-[4-(1,3-Oxazol-5-Yl)phenyl]-N-Oxidanyl-3-Phenyl-Cyclopropane-1-Carboxamide | IC50 | 30.0 [1] |
| (2R)-2-[(1-Hydroxy-6-sulfanylidenepyridine-2-carbonyl)amino]propanoic acid | IC50 | 50000.0 [1] |
| (2R)-2-[(1-Hydroxy-6-sulfanylidenepyridine-2-carbonyl)amino]-2-phenylacetic acid | IC50 | 49000.0 [1] |
| (7R)-N-Hydroxy-7-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-5,6,7,8-tetrahydronaphthalene-2-carboxamide | IC50 | 30800.0 [1] |
| N-Hydroxy-2-[[5-(3-nitrophenyl)furan-2-yl]methyl]-3,4-dihydro-1H-isoquinoline-7-carboxamide | IC50 | 60700.0 [1] |
| N-{4-[2-(4,6-Dimethyl-pyrimidin-2-ylsulfanyl)-acetyl]-phenyl}-acetamide | IC50 | 100000.0 [1] |
| (2S)-N'-Hydroxy-2-[[2-(5-methoxy-2-methyl-1H-indol-3-yl)acetyl]amino]-N-[2-(2-phenyl-1H-indol-3-yl)ethyl]octanediamide | IC50 | 4200.0 [1] |
| 2-(4-(4-(4-Fluorophenyl)-1-hydroxybut-3-en-2-yl)piperazin-1-yl)-N-hydroxypyrimidine-5-carboxamide | IC50 | 102.0 [1] |